Developer docs
API playgroundTry for free, no card

Search company profiles

Alpha Research Institute

Full company profile

uuid000uviy

Namestring
Alpha Research Institute
Legal namestring
Alpha Research Institute, LLC
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Alpha Research Institute, LLC is a privately held, Houston-based outpatient clinical research facility that conducts Phase I through Phase IV clinical trials for pharmaceutical companies, health organizations, and federal agencies. The institute recruits adult patients with named conditions — including Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Lupus, Celiac Disease, Graves' Disease, and NASH — as well as healthy volunteers for vaccine studies and infant donors for biological sample collection. The facility supports 16+ therapeutic areas spanning Asthma/Allergy, Nephrology, Neurology, Cardiac and Vascular Disorders, Dermatology, Oncology, Ophthalmology, Orthopedic, Gastrointestinal, Psychiatry, Infectious Diseases, Pulmonary/Respiratory, Internal Medicine, Urology, Obstetrics & Gynecology, and IDE studies in Orthopedics and Cardiovascular.

The institute operates an on-site laboratory with capabilities in cell culture, gene sequencing, and scanning electron microscopy, and is registered with the FDA with all studies reviewed by Institutional Review Boards. Participants receive free medical care from local doctors, compensation for study-related time and travel (typically tens to over one thousand dollars per study), and complimentary transportation within the Houston metro area; no insurance or citizenship documentation is required. The facility is staffed by a Director of Clinical Trials Operations, a Director, clinical and admin coordinators, a patient recruiter, and a medical advisor.

Revenue is generated on a professional services basis through per-study contracts with trial sponsors; participants are not paying customers. Distribution is direct-to-consumer via the institute's website, phone enrollment, and organic social media channels (Facebook, Twitter, Instagram, TikTok) supplemented by an educational blog. The geographic footprint is concentrated in the Houston metropolitan area and Texas, with no disclosed international operations, institutional investors, funding rounds, partnerships, or acquisitions.

Short descriptiontext

Alpha Research Institute is a Houston-based private clinical research site running Phase I-IV trials across 16+ therapeutic areas for pharmaceutical sponsors, recruiting volunteer patients and healthy participants with free care, compensation, and local transportation.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersHouston, United States
HQ citystring
Houston
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
clinical research services, clinical trial conduct, phase I-IV studies, therapeutic area trials, volunteer recruitment
Industry2 codes
1Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS)
CodeBPAGACAAPrimaryYes
2Research Administration & Compliance (Sponsored Programs, IRB/REB)
CodeEDADAKAHPrimaryNo
NAICS code3 codes
  • Medical and Diagnostic Laboratories62151
  • Medical Laboratories621511
  • Medical and Diagnostic Laboratories6215
SIC code3 codes
  • Services-Commercial Physical & Biological Research8731
  • Services-Medical Laboratories8071
  • Services-Testing Laboratories8734
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Clinical Trial Conduct Services
TypeProfessional Services
Description

Alpha Research Institute conducts clinical trials funded by pharmaceutical companies, health organizations, and federal agencies. The company receives compensation from sponsors to conduct research studies while participants receive free care and monetary compensation covered by sponsors.

alpharesearchinst.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales
Pricing details1 tier
1Free participation with compensation for volunteers
ModelOtherBilling cadencePay-as-you-go
Notes

Participants receive free medical care from local doctors at no cost. Compensation for study-related time and travel varies by study (hundreds to $1,000+). Specific studies like Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Celiac Disease, Lupus, and Grave's Disease offer $50 compensation.

alpharesearchinst.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Alpha Research Institute is a clinical research organization that conducts Phase I through Phase IV clinical trials across multiple therapeutic areas on behalf of pharmaceutical sponsors, health organizations, and federal agencies. It recruits volunteer participants in the Houston area for named studies covering conditions such as Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Lupus, Celiac Disease, Grave's Disease, and NASH. Participants receive free care, free transportation, and monetary compensation for time and travel.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • No cost for participation - all study costs covered by sponsors
Product overview1 text field

Alpha Research Institute operates as a clinical research facility offering Phase I to Phase IV clinical trials across multiple therapeutic areas including asthma/allergy, nephrology, neurology, cardiology, dermatology, oncology, and more. The company manages a portfolio of named clinical studies for conditions such as Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Grave's Disease, Lupus, Celiac Disease, and NASH, supplemented by infant biological sample collection services. Additional offerings include free transportation services for Houston-area participants and laboratory research capabilities (Cell Culture, Gene Sequencing, Scanning Electron Microscopy). The company recruits volunteer participants who receive compensation for their time and travel, with no insurance or citizenship requirements.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Recent move1 record

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Mid-to-large global CRO running Phase I–IV trials with dedicated site network. Comparable in therapeutic breadth and full-lifecycle service offering, though at much greater scale than Alpha.

TypeBroad incumbent
Description

Global clinical and commercial services company with site-management arm (formerly ACRP/Syneos Site Solutions). Comparable CRO/sponsor-facing business model operating at much larger scale.

TypeBroad incumbent
Description

Standalone CRO (spun from Labcorp) running Phase I–IV trials globally including site-services. Competes with Alpha for sponsor contracts and represents the kind of scaled entity sponsors often prefer.

TypeDirect peer
Description

Texas-based independent clinical research site operating across multiple therapeutic areas with DTC patient recruitment. Directly comparable site-network business model and patient-acquisition approach.

TypeBroad incumbent
Description

Global CRO with site-services division and dedicated site network post-PRA Health Sciences merger. Competes head-to-head with independent sites for Phase II–IV study placement.

TypeDirect peer
Description

Independent multi-therapeutic clinical research site network in Texas conducting Phase I–IV trials across diverse indications. Closely comparable in business model, scale, and therapeutic breadth to Alpha Research Institute.

TypeDirect peer
Description

Multi-site independent clinical research organization running trials across broad therapeutic areas for pharmaceutical sponsors. Directly comparable in therapeutic diversity and site-based delivery model.

TypeBroad incumbent
Description

Largest global CRO with proprietary site network and data platforms. Competes with independent sites for sponsor placement and sets the contracting standards smaller sites must operate within.

TypeDirect peer
Description

Independent clinical trial site in Texas offering Phase I–IV studies across multiple therapeutic areas. Operates the same site-network CRO model with similar sponsor mix and patient-recruitment tactics.

TypeEmerging player
Description

Consolidated multi-site clinical research network built by rolling up independent sites across the US. Most directly comparable as a competitor pursuing scale through acquisition of independent sites like Alpha.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles10 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Alpha Research Institute

Alpha Research Institute is a Houston-based private clinical research site running Phase I-IV trials across 16+ therapeutic areas for pharmaceutical sponsors, recruiting volunteer patients and healthy participants with free care, compensation, and local transportation.

What Alpha Research Institute does

Alpha Research Institute, LLC is a privately held, Houston-based outpatient clinical research facility that conducts Phase I through Phase IV clinical trials for pharmaceutical companies, health organizations, and federal agencies. The institute recruits adult patients with named conditions — including Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Lupus, Celiac Disease, Graves' Disease, and NASH — as well as healthy volunteers for vaccine studies and infant donors for biological sample collection. The facility supports 16+ therapeutic areas spanning Asthma/Allergy, Nephrology, Neurology, Cardiac and Vascular Disorders, Dermatology, Oncology, Ophthalmology, Orthopedic, Gastrointestinal, Psychiatry, Infectious Diseases, Pulmonary/Respiratory, Internal Medicine, Urology, Obstetrics & Gynecology, and IDE studies in Orthopedics and Cardiovascular.

The institute operates an on-site laboratory with capabilities in cell culture, gene sequencing, and scanning electron microscopy, and is registered with the FDA with all studies reviewed by Institutional Review Boards. Participants receive free medical care from local doctors, compensation for study-related time and travel (typically tens to over one thousand dollars per study), and complimentary transportation within the Houston metro area; no insurance or citizenship documentation is required. The facility is staffed by a Director of Clinical Trials Operations, a Director, clinical and admin coordinators, a patient recruiter, and a medical advisor.

Revenue is generated on a professional services basis through per-study contracts with trial sponsors; participants are not paying customers. Distribution is direct-to-consumer via the institute's website, phone enrollment, and organic social media channels (Facebook, Twitter, Instagram, TikTok) supplemented by an educational blog. The geographic footprint is concentrated in the Houston metropolitan area and Texas, with no disclosed international operations, institutional investors, funding rounds, partnerships, or acquisitions.

Alpha Research Institute firmographics

Firmographics
Name
Alpha Research Institute
Legal name
Alpha Research Institute, LLC
Website
https://alpharesearchinst.com
Company type
Private
Operating status
Operating
Headcount range
11–50 employees
Short description
Alpha Research Institute is a Houston-based private clinical research site running Phase I-IV trials across 16+ therapeutic areas for pharmaceutical sponsors, recruiting volunteer patients and healthy participants with free care, compensation, and local transportation.
Ownership category
akta.pro rank

Alpha Research Institute industry classification

Industry
NAICS
Medical and Diagnostic Laboratories (62151), Medical Laboratories (621511), Medical and Diagnostic Laboratories (6215)
SIC
Services-Commercial Physical & Biological Research (8731), Services-Medical Laboratories (8071), Services-Testing Laboratories (8734)
akta.pro primary industry
Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
akta.pro secondary industry
Research Administration & Compliance (Sponsored Programs, IRB/REB) (EDADAKAH)

Keywords

  • Clinical research services
  • Clinical trial conduct
  • Phase I-IV studies
  • Therapeutic area trials
  • Volunteer recruitment

Where Alpha Research Institute is headquartered

Location

Headquarters

HQ city
Houston
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Alpha Research Institute business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

  1. Clinical Trial Conduct Services: Alpha Research Institute conducts clinical trials funded by pharmaceutical companies, health organizations, and federal agencies. The company receives compensation from sponsors to conduct research studies while participants receive free care and monetary compensation covered by sponsors.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goFree participation with compensation for volunteers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Alpha Research Institute product offering

Product offering

Core offering

Alpha Research Institute is a clinical research organization that conducts Phase I through Phase IV clinical trials across multiple therapeutic areas on behalf of pharmaceutical sponsors, health organizations, and federal agencies. It recruits volunteer participants in the Houston area for named studies covering conditions such as Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Lupus, Celiac Disease, Grave's Disease, and NASH. Participants receive free care, free transportation, and monetary compensation for time and travel.

Product overview

Alpha Research Institute operates as a clinical research facility offering Phase I to Phase IV clinical trials across multiple therapeutic areas including asthma/allergy, nephrology, neurology, cardiology, dermatology, oncology, and more. The company manages a portfolio of named clinical studies for conditions such as Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Grave's Disease, Lupus, Celiac Disease, and NASH, supplemented by infant biological sample collection services. Additional offerings include free transportation services for Houston-area participants and laboratory research capabilities (Cell Culture, Gene Sequencing, Scanning Electron Microscopy). The company recruits volunteer participants who receive compensation for their time and travel, with no insurance or citizenship requirements.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

  • No cost for participation - all study costs covered by sponsors

Companies that use Alpha Research Institute

Customer profile

Segments3 records

Ideal customer profiles2 records

Alpha Research Institute technology and API

Technology

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Alpha Research Institute partnerships and signals

Strategic signal

Scale indicators1 record

Recent moves1 record

Expansion highlights4 records

Alpha Research Institute competitors and assessment

Company assessment

Broad incumbents

  • Medpace: Mid-to-large global CRO running Phase I–IV trials with dedicated site network. Comparable in therapeutic breadth and full-lifecycle service offering, though at much greater scale than Alpha.
  • Syneos Health: Global clinical and commercial services company with site-management arm (formerly ACRP/Syneos Site Solutions). Comparable CRO/sponsor-facing business model operating at much larger scale.
  • Labcorp Drug Development (now Fortrea): Standalone CRO (spun from Labcorp) running Phase I–IV trials globally including site-services. Competes with Alpha for sponsor contracts and represents the kind of scaled entity sponsors often prefer.
  • ICON plc: Global CRO with site-services division and dedicated site network post-PRA Health Sciences merger. Competes head-to-head with independent sites for Phase II–IV study placement.
  • IQVIA: Largest global CRO with proprietary site network and data platforms. Competes with independent sites for sponsor placement and sets the contracting standards smaller sites must operate within.

Direct peers

  • DM Clinical Research: Texas-based independent clinical research site operating across multiple therapeutic areas with DTC patient recruitment. Directly comparable site-network business model and patient-acquisition approach.
  • Clinical Trials of Texas: Independent multi-therapeutic clinical research site network in Texas conducting Phase I–IV trials across diverse indications. Closely comparable in business model, scale, and therapeutic breadth to Alpha Research Institute.
  • Research Across America: Multi-site independent clinical research organization running trials across broad therapeutic areas for pharmaceutical sponsors. Directly comparable in therapeutic diversity and site-based delivery model.
  • Biopharma Research: Independent clinical trial site in Texas offering Phase I–IV studies across multiple therapeutic areas. Operates the same site-network CRO model with similar sponsor mix and patient-recruitment tactics.

Emerging players

  • Velocity Clinical Research: Consolidated multi-site clinical research network built by rolling up independent sites across the US. Most directly comparable as a competitor pursuing scale through acquisition of independent sites like Alpha.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Alpha Research Institute social profiles

Digital presence

Alpha Research Institute financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Alpha Research Institute leadership team

Management profile

Number of profiles

Profiles10 records

Alpha Research Institute funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Alpha Research Institute M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alpha Research Institute

What does Alpha Research Institute do?

Alpha Research Institute is a clinical research organization that conducts Phase I through Phase IV clinical trials across multiple therapeutic areas on behalf of pharmaceutical sponsors, health organizations, and federal agencies. It recruits volunteer participants in the Houston area for named studies covering conditions such as Alzheimer's, Scleroderma, Crohn's Disease, Vaginitis, Lupus, Celiac Disease, Grave's Disease, and NASH. Participants receive free care, free transportation, and monetary compensation for time and travel.

Is Alpha Research Institute a public or private company?

Alpha Research Institute is a private company. It is currently operating.

When was Alpha Research Institute founded?

Alpha Research Institute was founded in -1. It employs 11 to 50 people.

Where is Alpha Research Institute based?

Alpha Research Institute is headquartered in Houston, United States, in the North America region.

How does Alpha Research Institute make money?

One revenue line is on record: clinical Trial Conduct Services.

Who are Alpha Research Institute's main competitors?

Broad incumbents on record are Medpace, Syneos Health, Labcorp Drug Development (now Fortrea), ICON plc and IQVIA. Direct peers are DM Clinical Research, Clinical Trials of Texas, Research Across America and Biopharma Research. Velocity Clinical Research is listed as an emerging player.

Does Alpha Research Institute have an API?

No public API is recorded for Alpha Research Institute.

What industry is Alpha Research Institute in?

Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of EDADAKAH, Research Administration & Compliance (Sponsored Programs, IRB/REB). Its NAICS code is 62151 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales